Thomas Bollyky

Thomas J. Bollyky is a visiting fellow at the Center for Global Development where he investigates the legal and ethical issues that arise during the discovery, development, and delivery of essential medical technologies to the developing world.

Mr. Bollyky was Director of Intellectual Property and Pharmaceutical Policy at the Office of the United States Trade Representative (USTR), where he led the negotiations for pharmaceuticals, biotechnology, and medical technologies in the U.S.-Republic of Korea Free Trade Agreement and represented USTR in the negotiations with China on safety of drug and medical device imports.  He was also a Fulbright Scholar to South Africa, where he worked as a staff attorney at the AIDS Law Project on treatment access issues related to HIV/AIDS, and a senior attorney at Debevoise & Plimpton LLP, where he represented Mexico before the International Court of Justice in Avena and other Mexican Nationals (Mexico v. United States of America) and José Ernesto Medellín before the United States Supreme Court in Medellin v. Dretke.  He is a former law clerk to Chief Judge Edward R. Korman, E.D.N.Y., an International Affairs Fellow at the Council on Foreign Relations, an Eesti and Eurasian Public Service Fellow at the Estonian Ministry of Education, and a health policy analyst, through the Outstanding Scholar Program, at the U.S. Department of Health and Human Services.  Mr. Bollyky received his B.A. in Biology and History at Columbia University and his J.D. at Stanford Law School, where he was the President of the Stanford Law & Policy Review.  He is a term member of the Council on Foreign Relations and a member of the New York and U.S. Supreme Court bars and the American Society of International Law.